RAFAEL HOLDINGS, INC. Common Stock, Value, Issued
RAFAEL HOLDINGS, INC. (RFL) had Common Stock, Value, Issued of $9.40 million as of 2025-03-25, per its 10-Q filed 2026-06-11.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-06-11
- 2025-03-25: Common Stock, Value, Issued $9.40M.
- 2023-04-30: Common Stock, Value, Issued $8.00K.
- 2023-01-31: Common Stock, Value, Issued $8.00K.
- 2022-10-31: Common Stock, Value, Issued $8.00K.
| Period end | Common Stock, Value, Issued |
|---|---|
| 2025-03-25 | $9.40M 10-Q · filed 2026-06-11 |
| 2023-04-30 | $8.00K 10-Q · filed 2023-06-13 |
| 2023-01-31 | $8.00K 10-Q · filed 2023-03-14 |
| 2022-10-31 | $8.00K 10-Q · filed 2022-12-13 |
| 2022-07-31 | $8.00K 10-Q · filed 2023-06-13 |
| 2022-04-30 | $8.00K 10-Q · filed 2022-06-14 |
| 2022-01-31 | $8.00K 10-Q · filed 2022-03-17 |
| 2021-10-31 | $8.00K 10-Q/A · filed 2022-02-28 |
| 2021-07-31 | $8.00K 10-K · filed 2022-10-31 |
| 2021-04-30 | $8.00K 10-Q · filed 2021-06-14 |
| 2020-07-31 | $8.00K 10-K · filed 2021-10-18 |
| 2018-01-31 | $40.55M 10-Q · filed 2018-03-12 |
| 2017-07-31 | $50.43M 10-Q · filed 2018-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |